Meet the 2026 Summer in the Field Fellow

Ubud, Indonesia. Photo by Geio Tischler via Unsplash.

The Boston University Global Development Policy (GDP) Center is proud to present the 2026 Summer in the Field Fellow: Luh Dewi. 

The GDP Center Summer in the Field Program provides a stipend to qualified graduate students to conduct field research or participate in otherwise unpaid internships for a dissertation project during the summer. The program enables students to take advantage of opportunities or field research to advance research supported by the GDP Center. 

 Summer in the Field Fellows spend ten weeks developing research skills and gaining professional experience by participating in a variety of research projects and internships in line with the GDP Center’s mission of advancing policy-oriented research for financial stability, human well-being and environmental sustainability across the globe.

Learn more about the 2026 Summer in the Field Fellow:

Luh Dewi is a Doctor of Public Health (DrPH) candidate at Boston University School of Public Health with experience in health systems strengthening, hospital pharmacy management, and cancer policy. Before joining BU, she worked with Indonesia’s Ministry of Health on the national Health Transformation Agenda and referral system reform.

Luh’s project explores how Indonesia can strengthen domestic pharmaceutical manufacturing while expanding equitable access to high-cost oncology biologics. It focuses on biosimilars, a more affordable alternative to originator biologics, which remain difficult to bring to market in many low- and middle-income countries. Using Indonesia as a case study, the project analyzes how industrial policy, regulatory systems, public financing, and procurement shape the domestic biosimilar market and patient access to cancer treatment.

Using the funding provided by the Summer in the Field fellowship, she will contribute to her dissertation and gather policy documents, map the biosimilar regulatory pathway, explore data access, and build stakeholder relationships beyond the Ministry of Health. Collaborating with colleagues at the Ministry will provide context for examining how policy alignment across health and non-health sectors affects biosimilar manufacturing and patient access. This support from the Global Development Policy Center will enable Luh to conduct in-country policy analysis and engage with stakeholders.